「Tuberculosis」の版間の差分

提供: Vaccipedia | Resources for Vaccines, Tropical medicine and Travel medicine
ナビゲーションに移動 検索に移動
 
(同じ利用者による、間の7版が非表示)
1行目: 1行目:
 +
{{TM menu}}
 +
 
==History==
 
==History==
 
*Died from or infected by Tb
 
*Died from or infected by Tb
100行目: 102行目:
 
*cardiac tamponade
 
*cardiac tamponade
 
*sequele - carcified pericardium
 
*sequele - carcified pericardium
 +
*very pauci-bacillary and bacterial investigation from pericardiocentesis is very much less sensitive
 +
 
====intestinal====
 
====intestinal====
 
*can mimic Crohn's disease
 
*can mimic Crohn's disease
161行目: 165行目:
 
*Gene Xpert
 
*Gene Xpert
 
**Xpert MTB/RIF
 
**Xpert MTB/RIF
**can detect drug resistant
+
**can detect resistance to rifampicin
  
 
====histopathology====
 
====histopathology====
181行目: 185行目:
 
*cannot distinguish between latent/active/used be treated
 
*cannot distinguish between latent/active/used be treated
  
==Treatment&Management==
+
==Treatment==
 
*needs prolonged Tx
 
*needs prolonged Tx
 
*needs multiple drugs
 
*needs multiple drugs
228行目: 232行目:
 
==Management==
 
==Management==
 
===paradoxical reaction===
 
===paradoxical reaction===
 +
*inflammation after commencing Tx
 +
*problematic in CNS, pericardial
 +
*co-Tx with steroids
 +
**CNS/meningitis,tuberculoma - dexamethasone
 +
**pericardial - predonisolone
 +
 +
===Directoly Observed Treatment, short course (DOTs)===
 +
*in high risk stuation
 +
*in homeless/chaotic social circumstance
 +
*in poor adherence/treatment failure
 +
 +
*Dr. Karlos Stybro
 +
 +
===TB in pregnancy===
 +
*RHZE are safe
 +
*supplementation with VitB6 (pyridoxine) recommended
 +
**hyperemesis gravidarum
 +
 +
===TB in breastfeeding===
 +
*no contraindication
 +
*rule out TB in baby
 +
 +
===hepatotoxicity===
 +
*any GI complaint may represent hepatotoxicity
 +
*suspend all TB drugs until lab test revealed
 +
*risk
 +
**co-infection HIV, hepB/C
 +
**other chronic liver disease
 +
**alcohol
 +
**advanced age
 +
*early - 2-3wks, R,H; good prognosis
 +
*late - after 1mo, E; bad prognosis
  
 
==Drug-resistant==
 
==Drug-resistant==
 +
===mono-resistant===
 +
*H-resistant approx. 7%
 +
 +
*primary resistance
 +
**infected by resistant TB
 +
*secondary resistance
 +
**
 +
 +
===multi-resistant MDR===
 +
*resistant to H and R
 +
*risk
 +
**previous Tx
 +
**household contact with MDR
 +
**HIV
 +
*resistance to R is a marker of MDR
 +
**90% of R-resistance strains are also resistant to H → GeneXpert
 +
 +
===extensively resistant XDR===
 +
*MDR + fluoroquinolone-resistant and at least one additional group A drug
 +
 +
===pre-extensively resistant pre-XDR===
 +
*MDR + fluoroquinolone-resistant

2021年6月4日 (金) 15:14時点における最新版

Navigation Menu Vac logo.png
General issues of Vaccine
Cold chain
Correlates of Protection
Vaccines for Asplenia
Vaccines for Pregnant women
Vaccines for Immunocompromised hosts
Vaccine hesitancy
Additional materials of vaccine
General issues of Tropical med.
Definition of Tropical Medicine
Matrices of tropical infection
General issues of Helminths
Neglected Tropical Diseases
Sexually-transmitted infections
Non-Communicable Diseases
Maternal health and contraception
Child health
Malnutrition and Micronutrient
Eosinophilia
Fever in the tropics
Diarrhea in the tropics
Anemia in the tropics
Dermatology in the tropics
Ophthalmology in the tropics
Neurology in the tropics
Mental health in the tropics
Surgery in the tropics
Humanitarian emergency
Epidemiology in outbreak
Antimicrobial resistance
Pathology of infectious diseases
General issues of Travel med.
Epidemiology of Travel health
Last minute traveler
Time zone issue
High altitude medicine
Diving medicine
Pregnancy and travel
Children and travel
Elderly and travel
Immunology
Principle of human immune system
Innate immunity
Cellular immunity
Humoral immunity
Neutralizing antibody and its assay
Antigenic Cartography
Additional materials of immunology
Epi & Stats
Basics & Definition
Epidemiology
Odds in statistics and Odds in a horse race
Collider bias
Data distribution
Statistical test
Regression model
Multivariate analysis
Marginal effects
Prediction and decision
Table-related commands in STATA
Missing data and imputation
Virus
HIV
HIV-TB co-infection
HIV-STI interaction
Viral Hemorrhagic Fever
Ebola
Crimean-Congo hemorrhagic fever
SFTS
Rabies
Polio
Dengue
Yellow fever
Chikungunya
Zika
Japanese encephalitis
Tick-borne encephalitis
Viral hepatitis
Measles
Smallpox and Monkeypox
Respiratory Syncytial virus
COVID-19
Bivalent BA.1/BA.4-5 mRNA vaccines
Monovalent XBB-1.5 mRNA vaccine
Private archives of the initial phase of the pandemic
Private archives of lecture materials of COVID vaccine as of March 2021
厚生労働省が発出する保健行政関連の文書の読み解き方
Bacteria
Bacteriological tests
Tuberculosis
Tuberculosis in Children
HIV-TB co-infection
Leprosy
Dermatological mycobacterium infecions
Syphilis and Yaws
Plague
Pneumococcus
Meningococcus
Typhoid
Salmonellosis
Melioidosis
Leptospirosis
Brucellosis
Bartonellosis
Lyme disease and Relapsing fever
Tularaemia
Tetanus
Diphtheria
Anthrax
Coxiellosis
Rickettsia
Rickettsiosis
Scrub typhus
Spotted fevers
Epidemic typhus
Murine typhus
Protozoa
Overview of protozoa
Overview of medicine for protozoa
Malaria
Chagas disease
African trypanosomiasis
Leishmaniasis
Trichomoniasis
Toxoplasmosis
Amoebiasis
Giardiasis
Cryptosporidiosis
Cyclosporiasis
Isosporiasis
Pentatrichomoniasis
Microsporidiasis
Babesiosis
Fungi
General issues of fungi
Coccidioidomycosis
Paracoccidioidomycosis
Histoplasmosis
Talaromycosis
Blastomycosis
Sporotrichosis
Nematode (roundworm)
Nematode principles
Lympatic filariasis
Onchocerciasis
Loiasis
Microscopic differentiation of microfilariae
Strongyloidiasis
Ascariasis
Ancylostomiasis (hookworm)
Trichuriasis (whipworm)
Enterobiasis (pinworm)
Angiostrongyliasis (rat lungworm)
Dracunculiasis (Guinea worm)
Anisakiasis
Trichinellosis (Trichinosis)
Gnathostomiasis
Spirurinasis
Soil-transmitted helminths
Trematode (fluke, distoma)
General issues of Helminths
Trematode principles
Schistosomiasis
Clonorchiasis
Fascioliasis
Paragonimiasis
Metagonimiasis
Cestode (tapeworm)
General issues of Helminths
Cestode principles
Diphyllobothriasis
Sparganosis
Taeniasis
Echinococcosis
Medical Zoology
Zoonosis
Insectology
Mosquitology
Acarology
Batology
Snake toxicology
Scorpion and spider toxicology
Marine toxicology

Chevron-up-blue.png

History

  • Died from or infected by Tb
    • John Keats (poet)
    • George O'well
    • Nelson Mandella
  • Hippocrates description
    • Phthisis (to waste away, consumption)
  • Robert Koch found the bacteria 1882

Epidemiology

est. case est. death all form 10mil 1.4mil HIV-ass 0.9 mil 208,000 MDR-Tb ≈558,000 ≈190,000

  • 8 countries account for 2/3 of all worldwide Tb
  1. India
  2. China
  3. Indonesia
  4. the Phillippines
  5. Pakistan
  6. Nigeria
  7. Bangladesh
  8. South Africa

Transmission

  • transmission-influencing factors
    • sputum status of index case
    • proximity - distance between each other
    • time
  • susceptibility of person
  • [math]\displaystyle{ R_0 \approx r \times c \times d }[/math]
    • [math]\displaystyle{ r }[/math] = transmissibility
      • to reduce [math]\displaystyle{ r }[/math]
        • ealier detection
        • rapid commencing of treatment
        • reduce aerolization (surgical masks on patients)
          • surgical masks on patients reduce infectivity by 56%
    • [math]\displaystyle{ c }[/math] = susceptibility of contacts
      • to reduce [math]\displaystyle{ c }[/math]
        • open windows
          • Tb airborne transmission risk: windows closed 97%, negative pressure room (ACH12) 39%, windows and doors fully open 33%
        • N95 respirator
        • ARTs for HIV patients
    • [math]\displaystyle{ d }[/math] = duration of infectivity
      • to reduce [math]\displaystyle{ d }[/math]
        • treat patients appropriately

Risk factors

  • HIV
  • malnutrition
    • Tb risk inversely correlates with BMI
  • diabetes
    • diabetes and Tb are syndemic
    • diabetes and Tb pathophysiologically exacerbate each other even under treatment condition in terms of hepatotoxicity
  • overcrowding
    • people per room vs Tb rate per 100,000 (in Canada)
      • 0.4-0.6 vs 18.9
      • 1.0-1.2 vs 113
  • ....

Natural history

  1. inhalation of M.tb containing droplets
  2. macrophages phagocytosis
  3. granuloma + lymphadenopathy
  4. Ghon complex - primary infection
    1. 5% local progression/disseminated Tb
    2. 95% latent Tb
      1. 10% of latent Tb reactivates in lifetime - secondary Tb

Latent Tb

  • 1/3 of the world's population have latent Tb
    • modelling approx. 1.7 bil. people
  • 10% of those latent Tb people get reactivation in their lifetime

Symptoms

  • cough ± sputum ± hemoptysis > 2weeks
  • fever
  • malaise
  • weight loss

Various presentations

pulmonary

    • 80-85% of TB diagnosis are pulmonary

extra-pulmonary

lymphadenitis - hilar/other

  • cold abscess
  • more common in cervical and hilar
  • possibly in axillar, inguinal and abdominal
  • hilar adenitis DDx - sarcoidosis, lymphoma, histoplasmosis

pleural

  • usually uni-lateral
  • effusion high LDH, high protein, high lymphocyte

pericardial

  • cardiac tamponade
  • sequele - carcified pericardium
  • very pauci-bacillary and bacterial investigation from pericardiocentesis is very much less sensitive

intestinal

  • can mimic Crohn's disease
  • most common in ileocecal

meningitis

  • often involves 3rd and 6th cranial nerves
  • meningeal irritation signs often unaccompanied

cerebral tuberculoma

  • DDx primary CNS lymphoma

Pott's disease (vertebral destruction due to TB)

  • kyphosis, gibbus formation
  • sometimes extends to psoas muscle abscess;

arthritis

  • synovial fluid does not necessarily contains enough TB bacteria; fluid culture may miss diagnosis
  • IGRA could be clue

skin

  • erythema nodosum
    • DDx - TB, cryptococcal, sarcoidosis, UC, oral contraceptive, ≈50% idiopathic
  • lupus vulgaris

miliary TB

  • massive lymphohematogenous dissemination
    • nodules diameter <10mm
  • liver
  • spleen
  • bone marrow
  • lungs
    • pulmonary miliary TB easily missed by chest X-ray
  • meninges

Diagnosis

baseline investigation

blood

  • full blood count
    • clues for TB - leukopenia, anemia, thrombocytopenia
  • liver enzyme, renal function, electrolyte
    • for baseline to monitor Tx side effect or to adjust dose
  • diabetes
  • co-infection
    • HIV
    • Hep B - HBsAg
    • Hep C - HCV-Ab

imaging

  • chest X-ray
  • other targeted imaging

microbiological

smear/microscopy

  • Ziehl-Neelsen of sputum
    • positive smear needs cavitation
    • children and HIV-positive tend not to cavitate
    • specificity 98%
  • fluorescent

culture - 4-8weeks

  • culture is definitive/reference standard
  • Lowenstein-Jensen medium
  • liquid medium 3 weeks

PCR TB DNA

  • Gene Xpert
    • Xpert MTB/RIF
    • can detect resistance to rifampicin

histopathology

  • tissue biopsy
    • caseating granuloma
      • multinucleated giant cells with nuclei arranged like a horseshoe

urinary LAM antigen detection

  • mycobacterial cell wall glycolipid antigen lipoarabinomannan (LAM)
  • marker of active TB
  • specificity 98%
  • sensitivity 40-70%

Manteau text/tuberculin skin test (TST)

  • low value for diagnosis

Interferon gamma release assay (IGRA)

  • T-SPOT/Quantiferon(QFT)
  • cannot distinguish between latent/active/used be treated

Treatment

  • needs prolonged Tx
  • needs multiple drugs

1st line target

  • cell wall synthesis
    • H - isoniazid (isoniotinic adid hydrozide)
    • E - ethanbutol
  • DNA synthesis
    • R - rifampicin
  • ?
    • Z - pyrazinamide
  • 2RHZE+4RH
  • 2RHZE+4(RH)₃

side effects

  • hepatotoxicity - H, R, Z
  • ocular toxicity - E
  • peripheral neuropathy - H
    • add vitamin B6 (pyridoxin)
  • gout - Z
  • fever - Z
  • lupus - H
  • drug interaction related to CYP 450P - R
    • carbamazepine
    • oral contraceptive
    • methadone

interrupted Tx

  • interrupted during intensive phase
    • interrupted for > 14 days - re-Tx from the beggining
    • interrupted for < 14 days - continue
  • during continuing phase

spinal/bone TB

  • needs 9 months

TB meningitis

  • needs 12 months
  • 2RHZE+10RH

latent TB

  • some options

Management

paradoxical reaction

  • inflammation after commencing Tx
  • problematic in CNS, pericardial
  • co-Tx with steroids
    • CNS/meningitis,tuberculoma - dexamethasone
    • pericardial - predonisolone

Directoly Observed Treatment, short course (DOTs)

  • in high risk stuation
  • in homeless/chaotic social circumstance
  • in poor adherence/treatment failure
  • Dr. Karlos Stybro

TB in pregnancy

  • RHZE are safe
  • supplementation with VitB6 (pyridoxine) recommended
    • hyperemesis gravidarum

TB in breastfeeding

  • no contraindication
  • rule out TB in baby

hepatotoxicity

  • any GI complaint may represent hepatotoxicity
  • suspend all TB drugs until lab test revealed
  • risk
    • co-infection HIV, hepB/C
    • other chronic liver disease
    • alcohol
    • advanced age
  • early - 2-3wks, R,H; good prognosis
  • late - after 1mo, E; bad prognosis

Drug-resistant

mono-resistant

  • H-resistant approx. 7%
  • primary resistance
    • infected by resistant TB
  • secondary resistance

multi-resistant MDR

  • resistant to H and R
  • risk
    • previous Tx
    • household contact with MDR
    • HIV
  • resistance to R is a marker of MDR
    • 90% of R-resistance strains are also resistant to H → GeneXpert

extensively resistant XDR

  • MDR + fluoroquinolone-resistant and at least one additional group A drug

pre-extensively resistant pre-XDR

  • MDR + fluoroquinolone-resistant